2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

The 20S Proteasome Is Active in Apoptotic Nanovesicles and Controls Anti-LG3 Antibody Production

M. Dieudé,^1,4 C. Bell,^2,4 J. Turgeon,^1,4 D. Beillevaire,^1,4 K. Hamelin,^1,4 S. Qi,^1,4 N. Pallet,^1,4 C. Rondeau,³ D. Gingras,³ M. Desjardins,³ P. Thibault,^2,4 M.-J. Hébert.^1,4
The Association Between Donor & Recipient Gene Variants and Tacrolimus Safety & Efficacy in a Diverse Cohort of Kidney Transplant Recipients

D. Taber, T. Srinivas, N. Pilch, M. Gebregziabher, L. Egede, P. Baliga, K. Chavin.
The Association of Basiliximab and Antithymocyte Globulin Induction With Delayed Graft Function

D. Felix,¹ B. Astor,² D. Hager,¹ A. Djamali.²
The Association of Systemic Indoleamine 2,3 Dioxygenase (IDO) Activity Simultaneous With Chronic Rejection On Allograft Kidney Biopsy

V. Dharnidharka, L. Hesemann, J. Mitsios, H. O'Gorman, M. Gunasekaran, D. Dietzen, T. Mohanakumar.
The Benefit of Hepatitis C Donor Kidney Transplantation Is Limited to Hepatitis C Positive Patients Over 50 Years of Age

T. Myint, A. Wright, C. Rose, C. Kennedy, J. Dong, J. Gill, J. Gill.
The Best Regimen With Rituximab for ABO-Incompatible Living Donor Liver Transplantation

H. Egawa,¹ K. Umeshita,² S. Uemoto.³
The Burden of Caregiving for Living Kidney Donors

H. Maple, N. Mamode.
The C1q-Binding Assays and Clinical Outcomes in Kidney Transplantation

P. Amico,¹ G. Hönger,¹ H. Hopfer,² R. Liwski.³
The Characteristics of Post-Operative Deep Vein Thrombosis in Kidney Transplant Recipients – Difference from Other Type of Surgery

J. Kim,¹ I. Moon,¹ M.-H. Kim,¹ K. Park,² S. Ahn,³ S. Park,⁴ S.-D. Kim,⁵ S. Kim.⁶
The Clinical Outcome of Plasma Cell-Rich Rejection of Kidney Allograft

J. Hasegawa,¹ K. Honda,² S. Wakai,¹ H. Shirakawa,³ M. Okumi,³ K. Omoto,³ H. Ishida,³ K. Tanabe.³

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z